LifeMD (NASDAQ:LFMD – Get Free Report) had its target price lowered by analysts at HC Wainwright from $13.00 to $9.00 in a note issued to investors on Wednesday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. HC Wainwright’s price objective indicates a potential upside of 126.87% from the stock’s previous close. Several [...]
LifeMD (NASDAQ:LFMD) Given New $9.00 Price Target at HC Wainwright
